Skip to content
Screener

Axogen AXGN Total Liabilities & Equity

Total Liabilities & Equity at other companies

Baxter International logo
Baxter InternationalBAX
$19.85B-6.8%
Stryker logo
StrykerSYK
$47.93B+3.5%
IAR
Integra LifeSciencesIART
$3.56B-2.8%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$640.55M+10.9%
Artivion logo
ArtivionAORT
$1.07B+27.9%
Bioventus logo
BioventusBVS
$673.35M-4.7%

Other financials

Income statement

See full
Revenue$69.7M+23.1%
Gross profit$50.7M+20.6%
Operating income-$2.2M-229%
Net income-$1.5M-362%
EPS (diluted)-$0.03-400%

Balance sheet

See full
Cash & equivalents$96.6M+271%
Total debt$20.1M-70.6%
Total equity$256.3M+128%
Total assets$304.9M+48.4%

Cash flow

See full
Operating cash flow$7.2M
CapEx$893.0K+23.7%
Free cash flow$6.3M

Valuation

See full
Market cap$2.5B+287%
Enterprise value$2.42B+252%
P/S9.9×+6.8×

Profitability

See full
Gross margin74.6%+0.3pp
Operating margin-5.1%
Net margin-13.4%-17.4pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Return on equity-18.2%-28.9pp
Debt / equity0.1×-0.5×
Current ratio6.6×+2.5×

Where this comes from

Reported directly by Axogen in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: Axogen’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000805928-26-000094
Line itemJune 30, 2026December 31, 2025
Total liabilities48,60692,840
Commitments and contingencies - see Note 14
Shareholders’ equity
Common stock, $0.01 par value per share; 100,000,000 shares authorized; 53,656,293 and 47,199,797 shares issued and outstanding, respectively537472
Additional paid-in capital583,783435,338
Accumulated deficit(328,063)(306,963)
Total shareholders’ equity256,257128,847
Total liabilities and shareholders’ equity$304,863$221,687

ITEM 1 — FINANCIAL STATEMENTS

FAQ

What is Axogen's total liabilities & equity?
Axogen (AXGN) reported total liabilities & equity of $304.86M in Q2 2026.
How has Axogen's total liabilities & equity changed year-over-year?
Axogen's total liabilities & equity increased by 48.4% year-over-year, from $205.45M to $304.86M.
What is the long-term trend for Axogen's total liabilities & equity?
Over 5 years (2020 to 2025), Axogen's total liabilities & equity has grown at a 1.9% compound annual growth rate (CAGR), from $201.38M to $221.69M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about Axogen's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude